Last reviewed · How we verify

Oraflex (BENOXAPROFEN)

FDA-approved withdrawn Small molecule Quality 21/100

At a glance

Generic nameBENOXAPROFEN
Drug classbenoxaprofen
TargetArachidonate 5-lipoxygenase
ModalitySmall molecule
Therapeutic areaImmunology
PhaseFDA-approved
First approval1982

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: